Delivering differently: Service delivery optimization to ensure sustainability of the HIV response

Anton Pozniak is an Immediate Past President of the International AIDS Society. He is Consultant Physician in HIV Medicine at the Chelsea and Westminster Hospital and Professor in the Department of Clinical Research at the London School of Hygiene and Tropical Medicine UK. He became a Fellow of the Royal College of Physicians in 1996 and a life member of the British HIV Association in 2014.

Helen McDowell is Head of Government Affairs & Global Public Health at ViiV Healthcare and was elected as the Industry Liaison Forum industry co-chair in July 2021. Helen, who has worked in HIV for over 15 years, leads global public policy, access to medicine, advocacy and global public health initiatives, including public-private partnerships, for ViiV Healthcare. She is also an active member of GSK’s (ViiV’s majority shareholder) Global Health Leadership team.

For over two decades, Wim Vandevelde has been committed to full-time action on HIV, hepatitis and TB treatment advocacy, education and medical research. Elected to the Board of Directors of the European AIDS Treatment Group (EATG) in 2004, he served as its Chairman until May 2009. Since then, Wim has chaired the EATG Research Working Group, the European Community Advisory Board and its Policy Working Group. EATG is the foremost HIV client advocate group in Europe, representing over 35 countries and working on HIV treatment and biomedical prevention research.

Wim is a founder and past President of the Portuguese HIV treatment group, GAT, and a member of the Core Group of the Stop TB Partnership Working Group on New Drugs. He has served as a member of the HIV/AIDS Civil Society Forum and the Think Tank of the European Commission (DG SANCO) and served two terms on the Steering Committee of AIDS Action Europe, the European platform of AIDS service organizations. He is the co-founder and past Chair of the Global TB Community Advisory Board.

Since June 2015, Wim has been the Liaison Officer at the Global Network of People living with HIV (GNP+) based in South Africa, supporting the Communities Delegation to the Unitaid Board. Previously, Wim worked in the banking industry in Belgium, Spain and Portugal. A native of Bruges, Belgium, Wim speaks Dutch, French, English and Portuguese.

Anna Grimsrud, MPH, PhD, is the Senior Technical Advisor at IAS – the International AIDS Society – within the HIV Programmes & Advocacy department. She holds a Master’s in Public Health and a PhD in epidemiology from the University of Cape Town, South Africa. Dr Grimsrud worked at the Treatment Action Campaign (TAC) and in implementation science and epidemiology as a scientist and lecturer at the University of Cape Town before joining IAS. Her academic work includes close collaborations with the Desmond Tutu Health Foundation (DTHF) and Médecins Sans Frontières (MSF). She has led projects funded by the Canadian Institutes of Health Research, the Global Fund and the Bill & Melinda Gates Foundation. Anna Grimsrud is a Deputy Editor at the Journal of the International AIDS Society (JIAS) and serves on a number of national, regional and global technical working groups on HIV.

Marco Vitoria is Medical Officer in the Department of HIV/AIDS at the World Health Organization (WHO) in Geneva, Switzerland. He has been in this role since 2003, providing technical support in treatment and care issues, consolidating global antiretroviral treatment guidelines and other normative documents, and training and evaluating HIV care programmes at the international level, particularly in resource-limited settings. Dr. Vitoria has an extensive experience in HIV clinical and programme management, having been involved in this field since the mid-1990s. From 1998 to 2003, he worked on HIV treatment scale-up in Brazil for the Brazilian National AIDS Programme.

Kimberly Green, PhD, leads PATH’s Primary Health Care program, a global team that works to advance health services and systems through innovation and partnerships. Prior to assuming this role, Kimberly Green led PATH’s global HIV, Viral Hepatitis and TB portfolio, including the USAID/PATH Healthy Markets project that advanced key population-led health services and differentiated service delivery models in Vietnam. Before joining PATH, Kimberly Green directed several global and regional primary health care efforts in Africa and Asia, partnering with ministries of health, communities and private sector to incubate and scale-up evidence-based approaches. She has worked with FHI 360, CARE, PACT and the Global Health Council.

Kimberly Green is Deputy Editor for the Journal of the International AIDS Society, Clinical Associate Professor in the University of Washington Global Health Program and oversees a number of implementation science studies. She holds a master’s degree in International Health and Development from The George Washington University in Washington, DC, and a PhD from the London School of Hygiene and Tropical Medicine.

Nelson Otwoma is the Executive Director of the National Empowerment Network of people living with HIV/AIDS in Kenya (NEPHAK) who works to provide strategic and accountable leadership to ensure the visibility and voice of people living with HIV and affected communities in the response to HIV and related coinfections and comorbidities. He is a member of a number of national, regional and global bodies and structures that work to improve the health and wellbeing of communities. He has worked with civil society organizations ad affected communities in the health sector, including over 15 years with the PLHIV community. He is member of the Kenya National ART Guidelines Technical Working Group and member of the Differentiated Service Delivery sub-Committee and now working to promote community based models of DSD, including the Community ART Groups (cARGs) in Kenya.

Peter Ehrenkranz, MD, MPH, is the Deputy Director, HIV at the Bill & Melinda Gates Foundation. From 2015 to 2021, Peter was the senior program officer for HIV treatment at the foundation. From 2009 to 2014, he worked in Eswatini (formerly Swaziland) under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Centers for Disease Control and Prevention, first as the care and treatment lead and later as the country director. Earlier, he spent two years as the medical director of the Clinton Health Access Initiative’s programs in Liberia, where he was embedded in the Ministry of Health as senior advisor to the National AIDS Control and the National Tuberculosis Control programs.

Peter earned an undergraduate degree from Yale University and medical and public health degrees from Emory University, and he both trained in internal medicine and completed the Robert Wood Johnson Clinical Scholars Program at the University of Pennsylvania.

In addition to his HIV responsibilities, Peter has led the foundation’s support for the local COVID-19 response in Seattle / King County and Washington State.

Nittaya Phanuphak, PhD, is Executive Director at the Institute of HIV Research and Innovation in Bangkok, Thailand. Nittaya graduated with her medical degree from the Faculty of Medicine at Chulalongkorn University, Thailand in 1996. In 2013, she received her PhD in Medicine from the University of Amsterdam, the Netherlands. Nittaya works actively with community and government partners to enhance access to HIV testing, prevention and treatment in the country. She started her career in the HIV field in 2002 to lead a country-wide prevention of mother-to-child transmission operational study which led Thai guidelines to allow the use of three-drug antiretroviral regimens for pregnant women in 2010. She has deep interest in Key Population-Led Health Services (KPLHS).

She currently works towards the establishment of national accreditation and domestic financing systems for lay providers to ensure KPLHS sustainability. She is the International AIDS Society (IAS) Governing Council Representative of Asia and the Pacific Islands, and previously served as Chief of the SEARCH and PREVENTION units of the Thai Red Cross AIDS Research Centre. Nittaya has published over 180 peer-reviewed articles. She serves as the Deputy Editor for the Journal of the International AIDS Society. She also provides ongoing research support to various studies as principal investigator or site-principal investigator.

Maurine Murenga is the Executive Director of Lean on Me Foundation and part of the Global Fund Advocates Network. She is a passionate advocate for the health, development, and human rights of women and girls. With a background in Public Health and Community Development, she is a pioneer amongst the young women and adolescent girls living with the HIV movement in Kenya. Maurine’s passion for advocacy is driven by her lived experience and the inequality and vulnerability that young women and adolescent girls experience in her community. In response to these challenges – she founded the Lean on Me Foundation – an organization that supports access to health services for young women living with HIV and affected by TB in Kenya. Maurine is currently the Executive Director of Lean on Me Foundation and Coordinator TB Women. She is a board member of Unitaid, Friends of the Fight US, and Elizabeth Glaser Pediatric AIDS Foundation - Kenya. Maurine is a member of Global Fund’s Audit and Finance Committee and Formerly a board member of the Global Fund to fight AIDS, TB, and Malaria.

Sínead Delany-Moretlwe, MBBCh PhD DTM&H is a clinical epidemiologist, Prof and Director of Research at Wits RHI. A South African-born medical doctor, her experience is primarily in sexual and reproductive health and HIV prevention research. She has supported HPV vaccine introduction into South Africa through her work and she is currently working with Australian and South African partners to evaluate the impact of South African national HPV vaccination programme. She is also part of a consortium aimed at evaluating the evidence for one dose HPV vaccination schedule. Sínead Delany-Moretlwe is an accomplished researcher who has been invited to speak at different international conferences which include the International AIDS Conference (IAS) 2018, HIV R4P 2018, and the STI & HIV World Congress where she has presented on new HIV prevention methods including PrEP. She is also a member of several national and international conference organising committees. In 2020 she contributed towards 14 manuscripts which were published in ISI indexed journals.

Sínead Delany-Moretlwe is a member of the WHO Product Development Vaccine Advisory Committee, the HSV vaccine advisory group, and a new group advising on gonorrhoea vaccine development for use in low and middle-income countries. She is also a member of University of the Witwatersrand’s Research Entities Committee.

Kenneth Ngure MPH, MSc, PhD is an Associate Professor and Chair of the Department of Community Health at the Jomo Kenyatta University of Agriculture and Technology, Kenya and Affiliate Associate Professor at the Department of Global Health, University of Washington. He is a recognized scientist in the fields of behavioral research, family planning, HIV Prevention and his current interests include antiretroviral based HIV prevention, HIV self-testing and interventions to reduce the risk of HIV transmission during peri-conception and pregnancy among HIV serodiscordant couples. Kenneth is also an elected member of the Governing Council of International AIDS Society (IAS) representing African region.

Helen Bygrave is a medical doctor who has worked in HIV and TB programming across Africa and Asia for the last 10 years. Recently, she has worked as IAS Differentiated Service Delivery consultant and HIV/TB advisor in the MSF Southern African Medical Unit supporting roll out of differentiated ART delivery models specifically in Zimbabwe, Lesotho, Malawi and Kenya.

Nittaya Phanuphak, PhD, is Executive Director at the Institute of HIV Research and Innovation in Bangkok, Thailand. Nittaya graduated with her medical degree from the Faculty of Medicine at Chulalongkorn University, Thailand in 1996. In 2013, she received her PhD in Medicine from the University of Amsterdam, the Netherlands. Nittaya works actively with community and government partners to enhance access to HIV testing, prevention and treatment in the country. She started her career in the HIV field in 2002 to lead a country-wide prevention of mother-to-child transmission operational study which led Thai guidelines to allow the use of three-drug antiretroviral regimens for pregnant women in 2010. She has deep interest in Key Population-Led Health Services (KPLHS).

She currently works towards the establishment of national accreditation and domestic financing systems for lay providers to ensure KPLHS sustainability. She is the International AIDS Society (IAS) Governing Council Representative of Asia and the Pacific Islands, and previously served as Chief of the SEARCH and PREVENTION units of the Thai Red Cross AIDS Research Centre. Nittaya has published over 180 peer-reviewed articles. She serves as the Deputy Editor for the Journal of the International AIDS Society. She also provides ongoing research support to various studies as principal investigator or site-principal investigator.